Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
复制标题
DOI：
10.1186/s40425-018-0477-9
复制
发表时间：
2018
影响因子：
10.9
通讯作者：
Zhang Li
中科院分区：
文献类型：
--
作者：
Zhou Yixin;Chen Chen;Zhang Xuanye;Fu Sha;Xue Cong;Ma Yuxiang;Fang Wenfeng;Yang Yunpeng;Hou Xue;Huang Yan;Zhao Hongyun;Hong Shaodong;Zhang Li
